Purpose: To investigate whether or not the age of spontaneous resolution of monosymptomatic nocturnal enuresis (MNE) was familial. Patients and Methods: A questionnaire was administered to more than 1,500 people, and 100 appropriate participants were identified from four referral hospitals. We included the participants who had MNE and whose parents also had MNE with spontaneous resolution. Then the association between the spontaneous resolution time of MNE in parents and that in their children was investigated. Results: The mean ages of spontaneous resolution were 10.7 (10-30 years), 9.4 (6-17 years) and 10.9 (6-18 years) in participants, their mothers and their fathers, respectively. According to the statistical analysis, there was a positive correlation between participants and both their mothers and fathers (p < 0.05). In addition, it was revealed that familial MNE history based on first- and second-degree relatives, in addition to their parents, was also associated with the increased spontaneous resolution age of MNE (p < 0.05). According to our results, gender and parents' education status were not statistically associated with the spontaneous resolution (p > 0.05). Conclusion: As a conclusion, the age of spontaneous resolution of MNE is familial. Although the exact reasons of spontaneous resolution still remain a mystery; further genetic investigations may be able to resolve this mystery.

Keywords:
Monosymptomatic nocturnal enuresis, Spontaneous resolution, Hereditary
1.
Tekgül S, Dogan HS, Hoebeke P, Kocvara R, Nijman JM, et al: Monosymptomatic enuresis; in Guidelines on Pediatric Urology, 2014, pp 51-53.
2.
Oğuz U, Sarıkaya S, Özyuvalı E, Şenocak Ç, Halis F, Çiftci M, Yıldırım YE, Bozkurt ÖF: Family compliance with the use of alarm devices in the treatment of monosymptomatic nocturnal enuresis. Turk J Urol 2014;40:52-55.
3.
Tuncel A, Mavituna I, Nalcacioglu V, Tekdogan U, Uzun B, Atan A: Long-term follow-up of enuretic alarm treatment in enuresis nocturna. Scand J Urol Nephrol 2008;42:449-454.
4.
Kwak KW, Park KH, Baek M: The efficacy of enuresis alarm treatment in pharmacotherapy-resistant nocturnal enuresis. Urology 2011;77:200-204.
5.
Kwak KW, Lee YS, Park KH, Baek M: Efficacy of desmopressin and enuresis alarm as first and second line treatment for primary monosymptomatic nocturnal enuresis: prospective randomized crossover study. J Urol 2010;184:2521-2526.
6.
Yeung CK, Sihoe JDY: Non-neuropatic dysfunction of the lower urinary tract in children. Campbell-Walsh urology. 10th edn. Saunders Elsevier, Philadelphia, pp 3411-3430.
7.
Loeys B, Hoebeke P, Raes A, Messiaen L, De Paepe A, Vande Walle J: Does monosymptomatic enuresis exist? A molecular genetic exploration of 32 families with enuresis/incontinence. BJU Int 2002;90:76-83.
8.
Eiberg H, Berendt I, Mohr J: Assignment of dominant inherited nocturnal enuresis (ENUR1) to chromosome 13q. Nat Genet 1995;10:354-356.
9.
Arnell H, Hjälmås K, Jägervall M, Läckgren G, Stenberg A, Bengtsson B, Wassén C, Emahazion T, Annerén G, Pettersson U, Sundvall M, Dahl N: The genetics of primary nocturnal enuresis: inheritance and suggestion of a second major gene on chromosome 12q. J Med Genet 1997;34:360-365.
10.
Eiberg H: Total genome scan analysis in a single extended family for primary nocturnal enuresis: evidence for a new locus (ENUR3) for primary nocturnal enuresis on chromosome 22q11. Eur Urol 1998;33(suppl 3):34-36.
11.
Park SJ, Park JM, Pai KS, Ha TS, Lee SD, Baek M; The Korean Children's Continence and Enuresis Society: Desmopressin alone versus desmopressin and an anticholinergic in the first-line treatment of primary monosymptomatic nocturnal enuresis: a multicenter study. Pediatr Nephrol 2014;29:1195-1200.
12.
Cobussen-Boekhorst HJ, van Genugten LJ, Postma J, Feitz WF, Kortmann BB: Treatment response of an outpatient training for children with enuresis in a tertiary health care setting. J Pediatr Urol 2013;9:516-520.
13.
Tauris LH, Andersen RF, Kamperis K, Hagstroem S, Rittig S: Reduced anti-diuretic response to desmopressin during wet nights in patients with monosymptomatic nocturnal enuresis. J Pediatr Urol 2012;8:285-290.
14.
Kwak KW, Park KH, Baek M: The efficacy of enuresis alarm treatment in pharmacotherapy-resistant nocturnal enuresis. Urology 2011;77:200-204.
15.
Yeung CK, Sihoe JD, Sit FK, Bower W, Sreedhar B, Lau J: Characteristics of primary nocturnal enuresis in adults: an epidemiological study. BJU Int 2004;93:341-345.
16.
Carman KB, Ceran O, Kaya C, Nuhoglu C, Karaman MI: Nocturnal enuresis in Turkey: prevalence and accompanying factors in different socioeconomic environments. Urol Int 2008;80:362-366.
17.
Naitoh Y, Kawauchi A, Soh J, Kamoi K, Miki T: Health related quality of life for monosymptomatic enuretic children and their mothers. J Urol 2012;188:1910-1914.
18.
Evans J, Malmsten B, Maddocks A, Popli HS, Lottmann H; UK study group: Randomized comparison of long-term desmopressin and alarm treatment for bedwetting. J Pediatr Urol 2011;7:21-29.
19.
Kanitkar M, Ramamurthy HR: Bed wetting - silent suffering: an approach to enuresis and voiding disorders in children. Indian J Pediatr 2013;80:750-753.
20.
Ferrara P, Ianniello F, Romani L, Fabrizio GC, Gatto A, Chiaretti A: Five years of experience in nocturnal enuresis and urinary incontinence in children: where we are and where we are going. Urol Int 2014;92:223-229.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.